Compare IOVA & TMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | TMC |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | Canada |
| Employees | N/A | 48 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2008 | N/A |
| Metric | IOVA | TMC |
|---|---|---|
| Price | $4.91 | $3.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $9.00 | $8.85 |
| AVG Volume (30 Days) | ★ 16.3M | 4.0M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $47.74 | N/A |
| Revenue Next Year | $40.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $3.57 |
| 52 Week High | $5.64 | $11.35 |
| Indicator | IOVA | TMC |
|---|---|---|
| Relative Strength Index (RSI) | 60.02 | 36.70 |
| Support Level | $3.77 | $3.57 |
| Resistance Level | $5.63 | $6.60 |
| Average True Range (ATR) | 0.40 | 0.23 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 68.35 | 26.21 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
TMC The Metals Co Inc is a deep seabed minerals developer focused on the collection, processing and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ), approximately 1,500 miles (or 2,400 kilometers) south-west of San Diego, California. The company operates as a single operating and reportable segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.